Abstract
This study was conducted to evaluate the accumulation and distribution of HGC (hydrophobically modified glycol chitosan) as a degradable nanoparticle in the body. To determine the movement of degradable HGC nanoparticles in the body, 20 mg/kg of lutetium-labeled HGC (Lu-HGC) with a size range from 320 to 400 nm was injected intravenously into ICR mice, and the amount of radioactivity remaining in blood and several organs was measured at various time points a period of 5 days. In the pharmacokinetics analysis using the Lu radioisotope, the free Lu was mainly distributed and accumulated in the order of kidney>liver>lung at 1 day after the injection of radioisotope. However, the Lu-HGC showed a high distribution of nanoparticles in the order of liver>spleen>kidney until 5 days. These results would provide a basic pharmacokinetics for the use of HGC as a drug carrier in drug delivery system.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
